A Research Genetic sequencing laboratory
This is a Phase II interventional study testing whether treatment with hydroxychloroquine, Vitamin C, Vitamin D, and Zinc can prevent infection with COVID-19. The study will last 24 weeks.
This Phase II interventional study will test the efficacy of quintuple therapy (Hydroxychloroquine, Azithromycin, Vitamin C, Vitamin D, and Zinc) in the treatment of patients with COVID-19 infection). The study will last 24 weeks.
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Chronic Fatigue Syndrome)
The investigators propose to ensure a favorable gut microbiome by fecal microbiota transplant to enhance the efficacy Keytruda
The terms REFLORALIZE™ and REFLORALIZATION™ were created by Sabine Hazan, MD, and are Trademarks, reference #19-38771
Copyright © ProgenaBiome™, LLC MMXIX -All Rights Reserved. 2019